Thought Leader?

I hardly know her!

Welcome to issue #7 of The Ethical Trip! In this issue:

  • What’s the deal with that top 100 thought leaders list?

  • Just how wrong is non-consensual dosing with psychedelics?

  • How to consistently write lots of words (yourself, not with an LLM)?

For all this, plus (back by popular demand) a roundup of recent research and jokes that some of you won’t let me stop writing, read on!

But first: Did we make it to 100 subscribers this week? No, but it’s very close! Thank you to everyone who has helped spread the word about my work and double-mega-thanks to people supporting me via buy me a coffee cacti.

Table of Contents

Industry Insights:

Research Round-up

It felt like a slower fortnight in psychedelic research. Nonetheless, there were still some interesting papers.

While not super-granular in nature data from Kamenderi et al (2025) suggests that use of psychoactives such as LSD are growing amongst Kenyan university students.

Hwang et al (2025) surveyed American college students on aptitudes around psychedelics and their use. ‘Males, sexual minorities, older students, those who were not religious, and those who used other substances evidenced more positive attitudes toward psychedelics, which in turn led to a higher likelihood of actual usage. Lifetime usage was also found to be directly associated with better mental health.’ No huge surprises but worth a look to see if Hwang’s (2021) Psychedelic Attitudes Scale could be used elsewhere.

Johnson-Groh (2025) discusses the potential entourage effect in magic mushrooms, noting some arguments both for and against its importance to psychedelic experience and clinical outcomes.

Evers et al (2025) is still in preprint, but if it makes it over the line their newly validated Psychedelic Media Exposure Questionnaire should become an important part of psychedelic research.

Lots more good stuff below, but only for subscribers!

Subscribe to keep reading

This content is free, but you must be subscribed to The Ethical Trip to continue reading.

I consent to receive newsletters via email. Terms of use and Privacy policy.

Already a subscriber?Sign in.Not now

Reply

or to participate.